Eli Lilly & Co. stock underperforms Tuesday when compared to competitors
Shares of Eli Lilly & Co. LLY slipped 6.59% to $744.91 Tuesday, on what proved to be an all-around great trading session for ...
These Stocks Are Moving the Most Today: Palantir, Nvidia, Eli Lilly, Boeing, KB Home, Signet, Aehr, and More
Palantir stock rebounds, sales of Eli Lilly’s blockbuster GLP-1 medicines miss estimates, and Boeing’s 2024 deliveries fall ...
After Eli Lilly's 7% Slump On Its Guidance Cut, What's Left To Like? A Lot, Says One Analyst.
There's still a lot to like about Eli Lilly stock, an analyst said Wednesday after the weight-loss drugs kingpin cut its ...
Wall Street Journal5d
Eli Lilly to Buy Scorpion Therapeutics Drug Program in $2.5 Billion Deal
For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. Eli Lilly has agreed to acquire Scorpion Therapeutics’ breast ...
Spectrum News NY14d
Wall Street mostly rises after encouraging inflation data despite Lilly’s drag
though drops for Eli Lilly and other influential stocks kept indexes in check. The S&P 500 rose 0.1% as three out of every four stocks in the index climbed. The Dow Jones Industrial ...
NBC Los Angeles6d
Dow rises more than 200 points on Tuesday after wholesale inflation report comes in light: Live updates
The Dow Jones Industrial Average rose on Tuesday as traders weighed ... they had for obesity drugs may not materialize as hoped. Lilly shares, which were approaching a trillion-dollar market ...
US stocks give up early gains to end mixed as investors await key consumer inflation data
US stocks gave up early gains to end mixed. Investors await key consumer inflation data and the start of earnings season on ...
Eli Lilly Stock Tumbles on Slower-Than-Expected Weight Loss Drug Sales. Is This a Buying Opportunity?
Eli Lilly unexpectedly lowered its full-year 2024 guidance. The miss appears to stem from a lack of the typical December ...